Clinical Trial Update: Reducing Cost of Azythromycin by Transferring From IV to Oral Therapy [NA]

View source ↗

Summary

A clinical trial evaluating cost reduction by switching from intravenous to oral azithromycin for pneumonia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Pneumonia | NA | Status: WITHDRAWN